---
title: "VERAXA Biotech (NASDAQ: VRXA) Partners With Ardigen to Advance AI-Driven Cancer Drug Development"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292516474.md"
description: "VERAXA Biotech (NASDAQ: VRXA) Partners With Ardigen to Advance AI-Driven Cancer Drug Development"
datetime: "2026-07-13T17:15:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292516474.md)
  - [en](https://longbridge.com/en/news/292516474.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292516474.md)
---

# VERAXA Biotech (NASDAQ: VRXA) Partners With Ardigen to Advance AI-Driven Cancer Drug Development


### Related Stocks

- [VRXA.US](https://longbridge.com/en/quote/VRXA.US.md)

## Related News & Research

- [Veraxa Biotech files first BiTAC-related patent applications for cancer therapy platforms](https://longbridge.com/en/news/294550628.md)
- [Veraxa Biotech partners with Ardigen on AI-enabled drug discovery for BiTAC pipeline](https://longbridge.com/en/news/292477238.md)
- [GRAL: Significant growth, clinical validation, and regulatory milestones position the test for broader adoption](https://longbridge.com/en/news/295557836.md)
- [Winklevoss-Backed Zcash faces Funding Crunch As $37.8M loss Puts Cancer Drug In The Spotlight](https://longbridge.com/en/news/295885103.md)
- [06:05 ETRyboDyn Unveils a Hidden Human Proteome and a New Universe of Actionable Cancer Targets](https://longbridge.com/en/news/295646300.md)